![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Hoy Sheridan M. Keating Gillian M.
Publisher: Adis International
ISSN: 1175-3277
Source: American Journal of Cardiovascular Drugs, Vol.10, Iss.5, 2010-10, pp. : 335-342
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
QOL in hypertension maintained with candesartan cilexetil
Inpharma, Vol. 1, Iss. 1244, 2000-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
QOL in hypertension maintained with candesartan cilexetil
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 269, 2000-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Candesartan Cilexetil: An Update of its Use in Essential Hypertension
Drugs, Vol. 62, Iss. 8, 2002-01 ,pp. :